ProfileGDS4718 / 1553982_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 39% 41% 40% 38% 35% 44% 37% 37% 41% 40% 38% 37% 36% 42% 40% 37% 37% 34% 36% 45% 44% 35% 40% 39% 38% 38% 36% 31% 38% 33% 41% 38% 33% 34% 38% 34% 40% 39% 43% 40% 34% 41% 40% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7590535
GSM549102patient 115, normal, homogenized [OPG study]4.9827239
GSM549104patient 119, normal, homogenized [OPG study]5.0301641
GSM549108patient 138, normal, homogenized [OPG study]5.0506240
GSM549119patient 077, normal, homogenized [OPG study]4.9053638
GSM549133patient 032, cancer, homogenized [OPG study]4.6881635
GSM549139patient 042, cancer, homogenized [OPG study]5.1587144
GSM549099patient 107, normal, homogenized [OPG study]4.8708737
GSM549109patient 139, normal, homogenized [OPG study]4.8810137
GSM549110patient 046, normal, homogenized [OPG study]5.0334141
GSM549114patient 063, normal, homogenized [OPG study]4.9558440
GSM549122patient 082, normal, homogenized [OPG study]4.9281938
GSM549134patient 033, cancer, homogenized [OPG study]4.8400337
GSM549136patient 036, cancer, homogenized [OPG study]4.7216536
GSM549140patient 044, cancer, homogenized [OPG study]5.0534942
GSM549111patient 047, normal, homogenized [OPG study]4.9900140
GSM549113patient 057, normal, homogenized [OPG study]4.7876637
GSM549132patient 031, cancer, homogenized [OPG study]4.8205237
GSM549137patient 038, cancer, homogenized [OPG study]4.706634
GSM549142patient 047, cancer, homogenized [OPG study]4.9329236
GSM549100patient 110, normal, homogenized [OPG study]5.2749145
GSM549107patient 135, normal, homogenized [OPG study]5.1526844
GSM549115patient 068, normal, homogenized [OPG study]4.7103835
GSM549116patient 072, normal, homogenized [OPG study]4.9645340
GSM549120patient 078, normal, homogenized [OPG study]4.9168239
GSM549131patient 030, cancer, homogenized [OPG study]4.8274438
GSM549118patient 074, normal, homogenized [OPG study]4.8854138
GSM549129patient 027, cancer, homogenized [OPG study]4.8045136
GSM549123patient 088, normal, homogenized [OPG study]4.5466631
GSM549124patient 006, cancer, homogenized [OPG study]4.9524638
GSM549126patient 015, cancer, homogenized [OPG study]4.6573833
GSM549128patient 025, cancer, homogenized [OPG study]5.0371241
GSM549103patient 117, normal, homogenized [OPG study]4.9717438
GSM549117patient 073, normal, homogenized [OPG study]4.6641933
GSM549138patient 041, cancer, homogenized [OPG study]4.704334
GSM549141patient 045, cancer, homogenized [OPG study]4.8337738
GSM549130patient 028, cancer, homogenized [OPG study]4.720434
GSM549101patient 111, normal, homogenized [OPG study]5.0170740
GSM549105patient 128, normal, homogenized [OPG study]4.9656939
GSM549106patient 134, normal, homogenized [OPG study]5.0808843
GSM549112patient 048, normal, homogenized [OPG study]4.9935140
GSM549125patient 011, cancer, homogenized [OPG study]4.7197634
GSM549127patient 024, cancer, homogenized [OPG study]5.0397741
GSM549135patient 035, cancer, homogenized [OPG study]4.9370540